Scienture Holdings [SCNX] vs Walgreens Boots [WBA] Detailed Stock Comparison

Scienture Holdings
NASDAQ
Loading...

Walgreens Boots
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Scienture Holdings wins in 9 metrics, Walgreens Boots wins in 8 metrics, with 0 ties. Scienture Holdings appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Scienture Holdings | Walgreens Boots | Better |
---|---|---|---|
P/E Ratio (TTM) | 2.37 | 27.10 | Scienture Holdings |
Price-to-Book Ratio | 0.25 | 1.46 | Scienture Holdings |
Debt-to-Equity Ratio | 5.30 | 409.88 | Scienture Holdings |
PEG Ratio | -0.04 | -0.18 | Walgreens Boots |
EV/EBITDA | -1.44 | 13.13 | Scienture Holdings |
Profit Margin (TTM) | 4.39% | -4.07% | Scienture Holdings |
Operating Margin (TTM) | -12,824.74% | 0.74% | Walgreens Boots |
EBITDA Margin (TTM) | N/A | 0.74% | N/A |
Return on Equity | -54.26% | -69.58% | Scienture Holdings |
Return on Assets (TTM) | -19.67% | 0.83% | Walgreens Boots |
Free Cash Flow (TTM) | $-14.27M | $-363.00M | Scienture Holdings |
Dividend Yield | 151.52% | 4.39% | Scienture Holdings |
1-Year Return | -86.47% | 18.45% | Walgreens Boots |
Price-to-Sales Ratio (TTM) | 152.25 | 0.07 | Walgreens Boots |
Enterprise Value | $23.63M | $39.76B | Walgreens Boots |
EV/Revenue Ratio | 184.29 | 0.26 | Walgreens Boots |
Gross Profit Margin (TTM) | N/A | 16.69% | N/A |
Revenue per Share (TTM) | $0 | $179 | Walgreens Boots |
Earnings per Share (Diluted) | $0.51 | $-7.29 | Scienture Holdings |
Beta (Stock Volatility) | N/A | 0.77 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Scienture Holdings vs Walgreens Boots Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Scienture Holdings | -4.46% | -51.80% | -50.00% | 16.30% | -60.81% | -82.17% |
Walgreens Boots | 0.99% | 2.61% | 5.90% | 8.64% | 16.08% | 32.75% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Scienture Holdings | -86.47% | -94.20% | -98.76% | -94.06% | -95.24% | -95.24% |
Walgreens Boots | 18.45% | -66.11% | -68.52% | -86.04% | -55.34% | -73.56% |
Performance & Financial Health Analysis: Scienture Holdings vs Walgreens Boots
Metric | SCNX | WBA |
---|---|---|
Market Information | ||
Market Cap | $19.52M | $10.46B |
Market Cap Category | Micro cap | Large cap |
10 Day Avg. Volume | 514,230 | 8,650,990 |
90 Day Avg. Volume | 323,230 | 6,625,323 |
Last Close | $1.07 | $12.20 |
52 Week Range | $0.69 - $9.55 | $8.08 - $13.25 |
% from 52W High | -88.80% | -7.92% |
All-Time High | $174.00 (Mar 23, 2020) | $97.30 (Aug 03, 2015) |
% from All-Time High | -99.39% | -87.46% |
Growth Metrics | ||
Quarterly Revenue Growth | -1.00% | 0.07% |
Quarterly Earnings Growth | -1.00% | 0.07% |
Financial Health | ||
Profit Margin (TTM) | 0.04% | -0.04% |
Operating Margin (TTM) | -128.25% | 0.01% |
Return on Equity (TTM) | -0.54% | -0.70% |
Debt to Equity (MRQ) | 5.30 | 409.88 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $4.83 | $8.30 |
Cash per Share (MRQ) | $0.00 | $0.96 |
Operating Cash Flow (TTM) | $-13,288,225 | $1.58B |
Levered Free Cash Flow (TTM) | $-2,928,467 | $4.52B |
Dividends | ||
Last 12-Month Dividend Yield | 151.52% | 4.39% |
Last 12-Month Dividend | $1.50 | $0.50 |
Valuation & Enterprise Metrics Analysis: Scienture Holdings vs Walgreens Boots
Metric | SCNX | WBA |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 2.37 | 27.10 |
Forward P/E | N/A | 8.22 |
PEG Ratio | -0.04 | -0.18 |
Price to Sales (TTM) | 152.25 | 0.07 |
Price to Book (MRQ) | 0.25 | 1.46 |
Market Capitalization | ||
Market Capitalization | $19.52M | $10.46B |
Enterprise Value | $23.63M | $39.76B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 184.29 | 0.26 |
Enterprise to EBITDA | -1.44 | 13.13 |
Risk & Other Metrics | ||
Beta | N/A | 0.77 |
Book Value per Share (MRQ) | $4.83 | $8.30 |
Financial Statements Comparison: Scienture Holdings vs Walgreens Boots
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SCNX | WBA |
---|---|---|
Revenue/Sales | $10,258 | $38.99B |
Cost of Goods Sold | $9,585 | $32.48B |
Gross Profit | $673 | $6.51B |
Research & Development | $574,679 | N/A |
Operating Income (EBIT) | $-3.57M | $13.00M |
EBITDA | $-3.63M | $624.00M |
Pre-Tax Income | $-3.06M | $-75.00M |
Income Tax | $0 | $126.00M |
Net Income (Profit) | $-3.06M | $-196.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SCNX | WBA |
---|---|---|
Cash & Equivalents | $2.05M | $766.00M |
Total Current Assets | $7.83M | $15.70B |
Total Current Liabilities | $7.46M | $25.96B |
Long-Term Debt | $1.23M | $26.17B |
Total Shareholders Equity | $81.16M | $7.32B |
Retained Earnings | $-42.10M | $19.83B |
Property, Plant & Equipment | $203,909 | $27.76B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SCNX | WBA |
---|---|---|
Operating Cash Flow | $-1.39M | $696.00M |
Capital Expenditures | N/A | $-248.00M |
Free Cash Flow | $-2.96M | $336.00M |
Debt Repayment | N/A | $-11.15B |
Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
Metric | SCNX | WBA |
---|---|---|
Shares Short | 46,933 | 23.08M |
Short Ratio | 0.20 | 3.80 |
Short % of Float | 0.00% | 0.04% |
Average Daily Volume (10 Day) | 514,230 | 8,650,990 |
Average Daily Volume (90 Day) | 323,230 | 6,625,323 |
Shares Outstanding | 8.75M | 864.00M |
Float Shares | 11.86M | 716.01M |
% Held by Insiders | 0.27% | 0.17% |
% Held by Institutions | 0.01% | 0.61% |
Dividend Analysis & Yield Comparison: Scienture Holdings vs Walgreens Boots
Metric | SCNX | WBA |
---|---|---|
Last 12-Month Dividend | $1.50 | $0.50 |
Last 12-Month Dividend Yield | 151.52% | 4.39% |
3-Year Avg Annual Dividend | $3.17 | $1.29 |
3-Year Avg Dividend Yield | 44.93% | 1.75% |
3-Year Total Dividends | $9.50 | $3.88 |
Ex-Dividend Date | Jul 19, 2024 | Nov 18, 2024 |